Additional work has shown that the intracellular content of the iron exporter ferroportin (FPN) was markedly downregulated in MDA-MB-231 BCC and associated with enhanced tumor growth both in vitro and in vivo, reverted by forced FPN expression. The gene discussed is SLC40A1; the disease is neoplasm.